Gyre Therapeutics
GYRE
#5736
Rank
C$1.18 B
Marketcap
$12.65
Share price
-0.76%
Change (1 day)
-42.50%
Change (1 year)

EPS for Gyre Therapeutics (GYRE)

EPS in 2024 (TTM): $0.14

According to Gyre Therapeutics's latest financial reports the company's current EPS (TTM) is -$1.96. In 2023 the company made an earnings per share (EPS) of -$1.96 a decrease over its 2022 EPS that were of $0.006044.

EPS history for Gyre Therapeutics from 2021 to 2024

Annual EPS

Year EPS Change
2024 (TTM)$0.14-107.34%
2023-$1.96-32451.8%
2022$0.006044-90.93%
2021$0.06660